FDA warns against CBD products while working on regulations

Only one drug containing cannabidiol (CBD) has been approved by the FDA — for treatment of rare and severe forms of epilepsy — and the agency is worried by the tide of products that tout CBD as a tonic. The FDA warned against use of unapproved products at the same time it said on Tuesday… » Read More

The Ag Insider content is only available to members.
Exit mobile version